MRSA bacteraemia cases acquired at RNOH have remained zero since 2009 which is lower than those seen in London and England. This is due to robust MRSA screening protocol for all patients being admitted to RNOH and this has been improved significantly through the years.
Surveillance continues for other organisms such as Meticilin Sensitive Staphylococcus aureus bacteraemias, Clostridium difficile toxin, Escherichia coli bacteraemia and also for surgical site infections. The robust surveillance programme to monitor infections ensures staff are made aware of trends, risk factors and clusters to ensure appropriate measures are taken at the earliest possible time to prevent avoidable infections.
In line with the Health and Social Care Act 2008, the RNOH has an appropriately constituted Infection Prevention and Control Team to provide expertise, knowledge and support to encourage and enable members of staff working across the trust to enhance and sustain their performance in ensuring patient safety by preventing avoidable infections.
The Trust has reported zero Meticilin Resistant Staphylococcus aureus (MRSA) blood stream infections since 2009 which remains lower than London and England. MRSA bacteraemia results remain zero as a result of the continued combined effort of all clinical and non clinical staff at RNOH. Such efforts include:
- Updated MRSA policy
- Staff training and education
- Robust MRSA screening protocol for all patients being admitted to RNOH
- Audit programme that includes checking the MRSA status of patients booked for theatre and feedback of results to staff
- MRSA IT flagging system to identify patients with previous MRSA
- Close liaison between bed management and infection control
- MRSA screening included on the admissions checklist
RNOH has not had any MRSA bacteraemia for 6 years running.
Further detail and information on MRSA: What is MRSA?
|MRSA screening protocol||814.41 KB|